Overview

Update
Total Equity Funding
$10.44M in 4 Rounds from 2 Investors
Most Recent Funding
$3.64M Venture on December 24, 2015
Headquarters:
Ayer, MA
Description:
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.
Founders:
,
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.alcyonels.com
Social:

Company Details

Update

Alcyone Lifesciences was founded in 2010 to address the unmet needs in treatment of chronic neuropathological conditions. For many neurologic conditions there are identified molecular targets, but the blood brain barrier prevents drugs addressing those targets from reaching diseased brain regions in a controlled and targeted manner. In addition, there is a fundamental need for control and precision in molecular therapy to the CNS. Alcyone Lifesciences has created a best-in-class platform technology which can optimize molecular therapy to the brain

Funding Rounds (4) - $10.44M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2015$3.64M / Venture0
Jan, 2014$4M / Series B2
May, 2013$1M / Private Equity0
Mar, 2012$1.8M / Series A0

Investors (2)

Current Team (6)

Update

Offices/Locations (1)

Update
  • Headquarters

    75 Sandy Point Road

    Unite 21

    Ayer, MA 01432

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos